CV Sciences, Inc. (CVSI)
USD 0.03
(6.25%)
USD 0.03
(6.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.25 Million | -1.88 Million | -7.48 Million | -7.3 Million | -2.13 Million | 12.55 Million |
| Net Income | 3.1 Million | -8.21 Million | -15.55 Million | -22.28 Million | -16.61 Million | 10 Million |
| Depreciation & Amortization | 347 Thousand | 992 Thousand | 1.15 Million | 872 Thousand | 716 Thousand | 519 Thousand |
| Deferred income taxes | -14 Thousand | -51 Thousand | -94 Thousand | 5.96 Million | -644 Thousand | -10 Thousand |
| Stock-based compensation | 218 Thousand | 1 Million | 3.21 Million | 3.88 Million | 15.12 Million | 2.92 Million |
| Change in working capital | 4.32 Million | 3.55 Million | 1.91 Million | 3.11 Million | -2.02 Million | -1.27 Million |
| Other non-cash items | -5.73 Million | 823 Thousand | 1.88 Million | 1.15 Million | 1.3 Million | 395 Thousand |
| Investing Cash Flow | -156 Thousand | - | -35 Thousand | -1.05 Million | -1.23 Million | -1.24 Million |
| Investments in PPE | - | - | -35 Thousand | -1.05 Million | -1.23 Million | -1.24 Million |
| Acquisitions | -156 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -35 Thousand | -1.05 Million | -1.14 Million | -351 Thousand |
| Financing Cash Flow | -1.39 Million | 1.12 Million | 4.37 Million | 3.27 Million | 47 Thousand | -1.17 Million |
| Debt repayment | -1.39 Million | -567 Thousand | -808 Thousand | -2.9 Million | -474 Thousand | -1.68 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 554 Thousand | 4.4 Million | 193 Thousand | 521 Thousand | 295 Thousand |
| Other Financing Activities | -1.39 Million | 1.12 Million | 771 Thousand | 5.98 Million | 47 Thousand | 219 Thousand |
| Accounts receivables | 352 Thousand | 1.06 Million | -989 Thousand | 918 Thousand | 927 Thousand | -1.88 Million |
| Accounts payables | -320 Thousand | -1.25 Million | 1.64 Million | -2.47 Million | 1.64 Million | 1.3 Million |
| Inventory | 1.04 Million | 2.06 Million | 216 Thousand | 1.7 Million | -1.66 Million | -60 Thousand |
| Other working capital | 2.93 Million | 1.68 Million | 1.04 Million | 2.95 Million | -2.92 Million | -637 Thousand |
| Cash at beginning of period | 611 Thousand | 1.37 Million | 4.52 Million | 9.6 Million | 12.93 Million | 2.79 Million |
| Cash at end of period | 1.31 Million | 611 Thousand | 1.37 Million | 4.52 Million | 9.6 Million | 12.93 Million |
| Capital Expenditure | - | - | -35 Thousand | -1.05 Million | -1.23 Million | -1.24 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 706 Thousand | -764 Thousand | -3.15 Million | -5.08 Million | -3.32 Million | 10.14 Million |
| Free Cash Flow | 2.25 Million | -1.88 Million | -7.52 Million | -8.35 Million | -3.37 Million | 11.31 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -584 Thousand | -628 Thousand | -869 Thousand | 3.1 Million | -447 Thousand | -1.28 Million |
| Depreciation & Amortization | 76 Thousand | 63 Thousand | 59 Thousand | 235 Thousand | 58 Thousand | 59 Thousand |
| Deferred income taxes | - | - | -14 Thousand | -14 Thousand | - | - |
| Stock-based compensation | 37 Thousand | 30 Thousand | 33 Thousand | 218 Thousand | 32 Thousand | 35 Thousand |
| Change in working capital | 314 Thousand | -119 Thousand | 359 Thousand | 4 Million | 255 Thousand | 2.31 Million |
| Other non-cash items | -9000.00 | 520 Thousand | 263 Thousand | -5.67 Million | 83 Thousand | 292 Thousand |
| Investing Cash Flow | -40 Thousand | - | -156 Thousand | -156 Thousand | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | -40 Thousand | - | -156 Thousand | -156 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -40 Thousand | - | - | - | - | - |
| Financing Cash Flow | -87 Thousand | -136 Thousand | -56 Thousand | -1.39 Million | -28 Thousand | -435 Thousand |
| Debt repayment | -87 Thousand | -136 Thousand | -56 Thousand | -1.39 Million | -28 Thousand | -435 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -87 Thousand | -136 Thousand | -56 Thousand | -1.39 Million | -28 Thousand | -435 Thousand |
| Accounts receivables | -130 Thousand | -70 Thousand | 249 Thousand | 352 Thousand | -45 Thousand | 46 Thousand |
| Accounts payables | -187 Thousand | -56 Thousand | -251 Thousand | -320 Thousand | 193 Thousand | -114 Thousand |
| Inventory | 615 Thousand | -102 Thousand | 208 Thousand | 1.04 Million | 107 Thousand | 690 Thousand |
| Other working capital | 16 Thousand | 109 Thousand | 153 Thousand | 2.93 Million | - | 1.69 Million |
| Cash at beginning of period | 662 Thousand | 1.31 Million | 1.64 Million | 611 Thousand | 1.69 Million | 714 Thousand |
| Cash at end of period | 477 Thousand | 662 Thousand | 1.31 Million | 1.31 Million | 1.64 Million | 1.69 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -1000.00 | -1000.00 | - | - | - | - |
| Net cash flow / Change in cash | -185 Thousand | -655 Thousand | -326 Thousand | 706 Thousand | -47 Thousand | 976 Thousand |
| Free Cash Flow | -57 Thousand | -518 Thousand | -114 Thousand | 2.25 Million | -19 Thousand | 1.41 Million |
9934
DRQ
6221
688318
HGH
ILM1